Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Полное описание

Библиографические подробности
Главные авторы:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Формат:	Статья
Язык:	Russian
Опубликовано:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Серии:	Проблемы особо опасных инфекций
Предметы:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
Online-ссылка:	https://journal.microbe.ru/jour/article/view/254

Схожие документы

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
по: E. I. Kazachinskaya, и др.
Опубликовано: (2015-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
по: Alexey Alekseevich Andreev, и др.
Опубликовано: (2020-06-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
по: A. A. Petrov, и др.
Опубликовано: (2020-05-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
по: A. A. Sominina, и др.
Опубликовано: (2015-10-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
по: A. V. Philippova, и др.
Опубликовано: (2019-10-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
по: Zh. I. Avdeeva, и др.
Опубликовано: (2018-02-01)

SMALL NONCODING RNA AS PERSPECTIVE BIOMARKERS: BIOGENESIS AND THERAPEUTIC STRATIGIES
по: V. V. Tiguntsev, и др.
Опубликовано: (2016-06-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
по: N. P. Khrapova, и др.
Опубликовано: (2015-03-01)

Safety issues of monoclonal antibodies used in rheumatology
по: A. V. Philippova, и др.
Опубликовано: (2020-01-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
по: A. A. Petrov, и др.
Опубликовано: (2015-09-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
по: O. O. Fomenkov, и др.
Опубликовано: (2015-06-01)

Study of protectivity and antigenicity of vaccine based on ' cultural Asia-1 No.2145/ Tajikistan/2011 FMD Virus
по: D. A. Lozovoy, и др.
Опубликовано: (2018-04-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
по: N. E. Tereshkina, и др.
Опубликовано: (2013-06-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
по: А. С. Пастиря, и др.
Опубликовано: (2017-06-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
по: I. I. Korsakova, и др.
Опубликовано: (2014-12-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
по: T. E. Sizikova, и др.
Опубликовано: (2015-09-01)

Diagnosis of hepatitis c today and interpretation of infection markers
по: T. V. Kozhanova
Опубликовано: (2013-12-01)

Antidiphtheria immunity at children with allergic diseases
по: A V Labushkina, и др.
Опубликовано: (2009-12-01)

Pharmacokinetic properties of the preparations of protein origin
по: A. A. Soldatov, и др.
Опубликовано: (2018-02-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
по: N. V. Bogacheva, и др.
Опубликовано: (2016-06-01)

Validation of the technique aimed at the determination of FMD antibodies in liquid phase blocking sandwich Elisa
по: N. N. Lugovskaya, и др.
Опубликовано: (2018-04-01)

Возможности сочетания иммунотерапии с лучевой терапией в лечении больных неоперабельным местно-распространённым немелкоклеточным раком легкого. Обзор литературы.
Опубликовано: (2021-06-01)

Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной инфекцией COVID-19 тяжелого течения. Ретроспективное когортное исследование
по: С. С. Бобкова, и др.
Опубликовано: (2021-03-01)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
по: D. L. Klabukova, и др.
Опубликовано: (2018-07-01)

Метод РНК-интерференции в защите растений от насекомых-вредителей
по: Владимир Сергеевич Журавлев, и др.
Опубликовано: (2022-04-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
по: I. V. Lyagoskin, и др.
Опубликовано: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
по: Елена Борисовна Лукоянычева, и др.
Опубликовано: (2023-02-01)

The morphological changes dynamics of ovarian reproductive apparatus in the experimental autoimmune oophoritis
по: M. L. Dmitriyeva, и др.
Опубликовано: (2012-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
по: G. N. Leonova, и др.
Опубликовано: (2017-04-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
по: A. A. Lidzhieva, и др.
Опубликовано: (2018-02-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
по: N. T. Tikhonova, и др.
Опубликовано: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
по: A. N. Mokrievich, и др.
Опубликовано: (2013-12-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
по: A. V. Vatazin, и др.
Опубликовано: (2021-01-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
по: V. G. Dedkov, и др.
Опубликовано: (2015-09-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
по: L. Yu. Aksenova, и др.
Опубликовано: (2013-12-01)

Antikeratin antibodies in rheumatoid arthritis
по: J Zabek
Опубликовано: (2003-02-01)

Заболявания, свързани с анти-миелинови олигодендроцитни гликопротеинови антитела (MOG-antibody diseases)
по: Sonia Ivanova, и др.
Опубликовано: (2019-09-01)

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications
по: - Bayati Ali Hattem Hussein, и др.
Опубликовано: (2012-09-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
по: A. A. Lopatin, и др.
Опубликовано: (2015-09-01)

Future Developments and Applications of the Vaccines against Dangerous Viral Infections, RNA-Replicon-Based, Obtained from the Venezuelan Equine Encephalomyelitis Virus
по: A. A. Petrov, и др.
Опубликовано: (2014-09-01)